Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
TB-500 is the cell-migration and tissue-remodelling peptide
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstrm syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
This approach offers the greatest immediate cost control
The objective is no longer simply to launch the most effective obesity drug, but to build a portfolio that supports patients throughout their treatment journey
Asking for the price at every strength before enrolling removes the surprise entirely
US$ 27.09
US$ 28.76
US$ 29.69
US$ 28.28
US$ 25.72
US$ 20.83
US$ 25.33
